Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T17:06:10.701Z.
Calculation as of: 2026-10-06T17:06:10.701Z.
Quote observation: 2026-10-06T17:04:50.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 95041c5b42fb2606cad9ef3462ba84fd1ad3ee370422abc55eb90f4681bfa3ac
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-04-30.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$874437.00
EV/FCF Ratio
N/A
TTM Avg
837938.26x
3Y Avg
5687338.31x
5Y Avg
5687338.31x
Market Cap
$880215.00
EV/FCF Ratio
N/A
TTM Avg
13238.43x
3Y Avg
13238.43x
5Y Avg
13238.43x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CDT Equity Inc. (CDT) | $668915.00 | N/A | N/A | N/A | N/A |
| HCW Biologics Inc. (HCWB)vs › | $559702.00 | N/A | N/A | N/A | N/A |
| Ridgetech, Inc. (RDGT)vs › | $791587.00 | N/A | 3.75x | 3.71x | 2.08x |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $837084.00 | N/A | N/A | N/A | N/A |
| XORTX Therapeutics Inc. (XRTX)vs › | $487356.00 | N/A | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $850879.00 | N/A | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $851149.00 | N/A | N/A | N/A | N/A |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $874437.00 | N/A | 837938.26x | 5687338.31x | 5687338.31x |
| Sunshine Biopharma, Inc. (SBFM)vs › | $880215.00 | N/A | 13238.43x | 13238.43x | 13238.43x |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2026-04-30 | 27.86x |
| 2026-04-29 | 27.86x |
| 2026-04-28 | 27.87x |
| 2026-04-27 | 27.87x |
| 2026-04-24 | 27.89x |
| 2026-04-23 | 27.91x |
| 2026-04-22 | 27.92x |
| 2026-04-21 | 27.93x |
| 2026-04-20 | 27.94x |
| 2026-04-17 | 27.94x |
| 2026-04-16 | 27.95x |
| 2026-04-15 | 0.02x |
| 2026-04-14 | 0.02x |
| 2026-04-13 | 0.02x |
| 2026-04-10 | 0.01x |
| 2026-04-09 | 0.04x |
| 2026-04-08 | 0.02x |
| 2026-04-07 | 0.01x |
| 2026-04-06 | 0.01x |
| 2026-04-02 | 0.01x |
| 2026-04-01 | 0.02x |
| 2026-03-31 | 0.02x |
| 2026-03-30 | 0.09x |
| 2026-03-27 | 0.07x |
| 2026-03-26 | 0.10x |
| 2026-03-25 | 0.11x |
| 2026-03-24 | 0.14x |
| 2026-03-23 | 0.13x |
| 2026-03-20 | 0.14x |
| 2026-03-19 | 0.13x |
| 2026-03-18 | 0.14x |
| 2026-03-17 | 0.14x |
| 2026-03-16 | 0.12x |
| 2026-03-13 | 0.13x |
| 2026-03-12 | 0.18x |
| 2026-03-11 | 0.17x |
| 2026-03-10 | 0.19x |
| 2026-03-09 | 0.21x |
| 2026-03-06 | 0.21x |
| 2026-03-05 | 0.21x |
| 2026-03-04 | 0.22x |
| 2026-03-03 | 0.19x |
| 2026-03-02 | 0.20x |
| 2026-02-27 | 0.22x |
| 2026-02-26 | 0.20x |
| 2026-02-25 | 0.22x |
| 2026-02-24 | 0.21x |
| 2026-02-23 | 0.23x |
| 2026-02-20 | 0.24x |
| 2026-02-19 | 0.31x |
| 2026-02-18 | 0.35x |
| 2026-02-17 | 0.38x |
| 2026-02-13 | 0.37x |
| 2026-02-12 | 0.35x |
| 2026-02-11 | 0.38x |
| 2026-02-10 | 0.39x |
| 2026-02-09 | 0.40x |
| 2026-02-06 | 0.39x |
| 2026-02-05 | 0.34x |
| 2026-02-04 | 0.36x |
| 2026-02-03 | 0.47x |
| 2026-02-02 | 0.38x |
| 2026-01-30 | 0.37x |
| 2026-01-29 | 0.38x |
| 2026-01-28 | 0.39x |
| 2026-01-27 | 0.38x |
| 2026-01-26 | 0.43x |
| 2026-01-23 | 0.42x |
| 2026-01-22 | 0.50x |
| 2026-01-21 | 0.51x |
| 2026-01-20 | 0.52x |
| 2026-01-16 | 0.50x |
| 2026-01-15 | 0.48x |
| 2026-01-14 | 0.50x |
| 2026-01-13 | 0.50x |
| 2026-01-12 | 0.52x |
| 2026-01-09 | 0.54x |
| 2026-01-08 | 0.55x |
| 2026-01-07 | 0.53x |
| 2026-01-06 | 0.54x |
| 2026-01-05 | 0.50x |
| 2026-01-02 | 0.51x |
| 2025-12-31 | 0.45x |
| 2025-12-30 | 0.46x |
| 2025-12-29 | 0.50x |
| 2025-12-26 | 0.51x |
| 2025-12-24 | 0.57x |
| 2025-12-23 | 0.57x |
| 2025-12-22 | 0.60x |
| 2025-12-19 | 0.59x |
| 2025-12-18 | 0.61x |
| 2025-12-17 | 0.59x |
| 2025-12-16 | 0.62x |
| 2025-12-15 | 0.64x |
| 2025-12-12 | 0.63x |
| 2025-12-11 | 0.66x |
| 2025-12-10 | 0.73x |
| 2025-12-09 | 0.64x |
| 2025-12-08 | 0.72x |
| 2025-12-05 | 0.65x |
| 2025-12-04 | 0.66x |
| 2025-12-03 | 0.61x |
| 2025-12-02 | 0.58x |
| 2025-12-01 | 0.59x |
| 2025-11-28 | 0.75x |
| 2025-11-26 | 0.76x |
| 2025-11-25 | 0.67x |
| 2025-11-24 | 0.63x |
| 2025-11-21 | 0.60x |
| 2025-11-20 | 0.60x |
| 2025-11-19 | 0.63x |
| 2025-11-18 | 0.77x |
| 2025-11-17 | 0.81x |
| 2025-11-14 | 0.82x |
| 2025-11-13 | 0.86x |
| 2025-11-12 | 0.93x |
| 2025-11-11 | 0.99x |
| 2025-11-10 | 0.99x |
| 2025-11-07 | 0.94x |
| 2025-11-06 | 0.92x |
| 2025-11-05 | 0.92x |
| 2025-11-04 | 0.91x |
| 2025-11-03 | 0.93x |
| 2025-10-31 | 1.07x |
